Meijering Sofie, Corstjens Anouk M, Tulleken Jaap E, Meertens John H J M, Zijlstra Jan G, Ligtenberg Jack J M
Intensive & Respiratory Care Unit (ICB), University Medical Center Groningen, Groningen, The Netherlands.
Crit Care. 2006 Feb;10(1):R19. doi: 10.1186/cc3981.
Tight glycaemic control is an important issue in the management of intensive care unit (ICU) patients. The glycaemic goals described by Van Den Berghe and colleagues in their landmark study of intensive insulin therapy appear difficult to achieve in a real life ICU setting. Most clinicians and nurses are concerned about a potentially increased frequency of severe hypoglycaemic episodes with more stringent glycaemic control. One of the steps we took before we implemented a glucose regulation protocol was to review published trials employing insulin/glucose algorithms in critically ill patients.
We conducted a search of the PubMed, Embase and Cochrane databases using the following terms: 'glucose', 'insulin', 'protocol', 'algorithm', 'nomogram', 'scheme', 'critically ill' and 'intensive care'. Our search was limited to clinical trials conducted in humans. The aim of the papers selected was required to be glycaemic control in critically ill patients; the blood glucose target was required to be 10 mmol/l or under (or use of a protocol that resulted in a mean blood glucose = 10 mmol/l). The studies were categorized according to patient type, desired range of blood glucose values, method of insulin administration, frequency of blood glucose control, time taken to achieve the desired range for glucose, proportion of patients with glucose in the desired range, mean blood glucose and frequency of hypoglycaemic episodes.
A total of twenty-four reports satisfied our inclusion criteria. Most recent studies (nine) were conducted in an ICU; nine others were conducted in a perioperative setting and six were conducted in patients with acute myocardial infarction or stroke. Studies conducted before 2001 did not include normoglycaemia among their aims, which changed after publication of the study by Van Den Berghe and coworkers in 2001; glycaemic goals became tighter, with a target range between 4 and 8 mmol/l in most studies.
Studies using a dynamic scale protocol combining a tight glucose target and the last two blood glucose values to determine the insulin infusion rate yielded the best results in terms of glycaemic control and reported low frequencies of hypoglycaemic episodes.
严格控制血糖是重症监护病房(ICU)患者管理中的一个重要问题。范登伯格及其同事在具有里程碑意义的强化胰岛素治疗研究中所描述的血糖目标,在现实生活中的ICU环境中似乎难以实现。大多数临床医生和护士担心,更严格的血糖控制可能会增加严重低血糖事件的发生频率。在实施血糖调节方案之前,我们采取的步骤之一是回顾已发表的在危重病患者中采用胰岛素/葡萄糖算法的试验。
我们使用以下术语检索了PubMed、Embase和Cochrane数据库:“葡萄糖”、“胰岛素”、“方案”、“算法”、“列线图”、“方案”、“危重病”和“重症监护”。我们的检索仅限于在人类中进行的临床试验。所选论文的目的必须是控制危重病患者的血糖;血糖目标必须在10 mmol/L或以下(或使用导致平均血糖 = 10 mmol/L的方案)。这些研究根据患者类型、期望的血糖值范围、胰岛素给药方法、血糖控制频率、达到期望血糖范围所需的时间、血糖在期望范围内的患者比例、平均血糖和低血糖事件的频率进行分类。
共有24份报告符合我们的纳入标准。最近的研究(9项)在ICU中进行;另外9项在围手术期进行,6项在急性心肌梗死或中风患者中进行。2001年之前进行的研究其目标中不包括血糖正常,在范登伯格及其同事于2001年发表研究之后情况发生了变化;血糖目标变得更严格,大多数研究中的目标范围在4至8 mmol/L之间。
就血糖控制而言,使用动态量表方案结合严格的血糖目标和最近两次血糖值来确定胰岛素输注速率的研究取得了最佳效果,且报告的低血糖事件发生率较低。